BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28691338)

  • 21. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications.
    Hu Z; Ma D
    Cancer Med; 2018 Oct; 7(10):5217-5236. PubMed ID: 30589505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary prevention of cervical cancer.
    Basu P; Mittal S; Bhadra Vale D; Chami Kharaji Y
    Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():73-85. PubMed ID: 28988647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State of the Science of Scale-Up of Cancer Prevention and Early Detection Interventions in Low- and Middle-Income Countries: A Scoping Review.
    Friebel-Klingner TM; Alvarez GG; Lappen H; Pace LE; Huang KY; Fernández ME; Shelley D; Rositch AF
    JCO Glob Oncol; 2024 Jan; 10():e2300238. PubMed ID: 38237096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knowledge of cervical cancer screening among Omani women attending a university teaching hospital: a cross-sectional study.
    M Al Kindi R; H Al Sumri H; M Al Muhdhoori T; Al Mamari K; A Al Kalbani M; H Al-Azri M
    BMC Womens Health; 2024 Jan; 24(1):40. PubMed ID: 38218830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention.
    Haldar SD; Vilar E; Maitra A; Zaidi N
    Cancer Prev Res (Phila); 2023 Sep; 16(9):483-495. PubMed ID: 37001882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thousands of Women's Lives Depend on the Improvement of Poland's Cervical Cancer Screening and Prevention Education as Well as Better Networking Strategies Amongst Cervical Cancer Facilities.
    Śniadecki M; Poniewierza P; Jaworek P; Szymańczyk A; Andersson G; Stasiak M; Brzeziński M; Bońkowska M; Krajewska M; Konarzewska J; Klasa-Mazurkiewicz D; Guzik P; Wydra DG
    Diagnostics (Basel); 2022 Jul; 12(8):. PubMed ID: 35892517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Not Available].
    Doleeb Z; Tesfaye M; Selk A; Dunn S; Maxwell C
    Can Fam Physician; 2022 Feb; 68(2):99-102. PubMed ID: 35177497
    [No Abstract]   [Full Text] [Related]  

  • 29. The pandemic and cervical cancer screening: Is it finally time to adopt HPV self-swabbing tests in Canada?
    Doleeb Z; Tesfaye M; Selk A; Dunn S; Maxwell C
    Can Fam Physician; 2022 Feb; 68(2):90-92. PubMed ID: 35177494
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical Utility of Reflex Testing with Cancer Biomarkers to Improve Diagnostic Accuracy of Primary Human Papillomavirus Screening.
    Johnson LG; Saidu R; Svanholm-Barrie C; Boa R; Moodley J; Tergas A; Persing D; Campbell SA; Tsai WY; Wright TC; Denny L; Kuhn L
    Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):595-603. PubMed ID: 35027434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Smartphones for the Detection of Uterine Cervical Cancer: A Systematic Review.
    Champin D; Ramírez-Soto MC; Vargas-Herrera J
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computer-aided diagnostic system based on deep learning for classifying colposcopy images.
    Liu L; Wang Y; Liu X; Han S; Jia L; Meng L; Yang Z; Chen W; Zhang Y; Qiao X
    Ann Transl Med; 2021 Jul; 9(13):1045. PubMed ID: 34422957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects.
    Tsu VD; LaMontagne DS; Atuhebwe P; Bloem PN; Ndiaye C
    Prev Med; 2021 Mar; 144():106335. PubMed ID: 33678232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smartphone-Enhanced Training, QA, Monitoring, and Evaluation of a Platform for Secondary Prevention of Cervical Cancer: Opportunities and Challenges to Implementation in Tanzania.
    Yeates K; Erwin E; Mtema Z; Magoti F; Nkumbugwa S; Yuma S; Hopman WM; Ferguson A; Oneko O; Macheku G; Mtei AF; Smith C; Andrews L; West N; Dalton M; Newcomb A; Ginsburg O
    JCO Glob Oncol; 2020 Jul; 6():1114-1123. PubMed ID: 32692627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The challenges of colposcopy for cervical cancer screening in LMICs and solutions by artificial intelligence.
    Xue P; Ng MTA; Qiao Y
    BMC Med; 2020 Jun; 18(1):169. PubMed ID: 32493320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical Cancer Screening with Human Papillomavirus Self-Sampling Among Transgender Men in El Salvador.
    Maza M; Meléndez M; Herrera A; Hernández X; Rodríguez B; Soler M; Alfaro K; Masch R; Conzuelo-Rodríguez G; Obedin-Maliver J; Cremer M
    LGBT Health; 2020; 7(4):174-181. PubMed ID: 32407149
    [No Abstract]   [Full Text] [Related]  

  • 37. Dominican Provider Attitudes Towards HPV Testing for Cervical Cancer Screening and, Current Challenges to Cervical Cancer Prevention in the Dominican Republic: a Mixed Methods Study.
    Liebermann E; Van Devanter N; Frías Gúzman N; Hammer MJ; Ompad D
    J Cancer Educ; 2021 Dec; 36(6):1170-1185. PubMed ID: 32307667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominican Provider Practices for Cervical Cancer Screening in Santo Domingo and Monte Plata Provinces.
    Liebermann E; Hammer MJ; Gúzman NF; Van Devanter N; Ompad D
    J Cancer Educ; 2021 Aug; 36(4):693-701. PubMed ID: 31953801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.
    Arbyn M; Weiderpass E; Bruni L; de Sanjosé S; Saraiya M; Ferlay J; Bray F
    Lancet Glob Health; 2020 Feb; 8(2):e191-e203. PubMed ID: 31812369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.
    Torres-Ibarra L; Cuzick J; Lorincz AT; Spiegelman D; Lazcano-Ponce E; Franco EL; Moscicki AB; Mahmud SM; Wheeler CM; Rivera-Paredez B; Hernández-López R; León-Maldonado L; Salmerón J;
    JAMA Netw Open; 2019 Nov; 2(11):e1915781. PubMed ID: 31747033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.